Literature DB >> 20000302

Evening primrose oil.

Bryan Bayles1, Richard Usatine.   

Abstract

Evening primrose oil (Oenothera biennis) is a commonly used alternative therapy and a rich source of omega-6 essential fatty acids. It is best known for its use in the treatment of systemic diseases marked by chronic inflammation, such as atopic dermatitis and rheumatoid arthritis. It is often used for several women's health conditions, including breast pain (mastalgia), menopausal and premenstrual symptoms, cervical ripening, and labor induction or augmentation. However, there is insufficient evidence to make a reliable assessment of its effectiveness for most clinical indications. The current evidence suggests that oral evening primrose oil does not provide clinically significant improvement in persons with atopic dermatitis, and that it is also likely ineffective for the treatment of cyclical mastalgia and premenstrual syndrome. However, most trials to date have significant methodologic flaws and must be considered preliminary. The use of evening primrose oil during pregnancy is not supported in the literature and should be avoided. Evening primrose oil is generally well tolerated, with reported minor adverse effects, including gastrointestinal upset and headaches. Optimal dosing standards and treatment regimens await clarification in adequately powered clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20000302

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  25 in total

1.  Motivations for Botanical Use by Socioeconomically Diverse, Urban Adults: Does Evidence Support Motivation?

Authors:  Grace F Duffy; Emily Stave Shupe; Marie Fanelli Kuczmarski; Alan B Zonderman; Michele K Evans
Journal:  J Altern Complement Med       Date:  2017-02-16       Impact factor: 2.579

Review 2.  Complementary and alternative medicine in the treatment of menopausal symptoms.

Authors:  Chong Shou; Justin Li; Zitao Liu
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

3.  Vitamin D and Evening Primrose Oil Administration Improve Glycemia and Lipid Profiles in Women with Gestational Diabetes.

Authors:  Mehri Jamilian; Maryam Karamali; Mohsen Taghizadeh; Nasrin Sharifi; Zahra Jafari; Mohammad Reza Memarzadeh; Mahnaz Mahlouji; Zatolla Asemi
Journal:  Lipids       Date:  2016-01-19       Impact factor: 1.880

Review 4.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

5.  Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats.

Authors:  Noha M Abo-Gresha; Eman Z Abel-Aziz; Sahar M Greish
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-03-13

6.  Prevalence of premenstrual symptoms: Preliminary analysis and brief review of management strategies.

Authors:  J V Joshi; S N Pandey; P Galvankar; J A Gogate
Journal:  J Midlife Health       Date:  2010-01

7.  Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis.

Authors:  Bo Young Chung; Jin Hye Kim; Soo Ick Cho; In Su Ahn; Hye One Kim; Chun Wook Park; Cheol Heon Lee
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

Review 8.  Physical health care monitoring for people with serious mental illness.

Authors:  Graeme Tosh; Andrew V Clifton; Jun Xia; Margueritte M White
Journal:  Cochrane Database Syst Rev       Date:  2014-01-17

Review 9.  Oral evening primrose oil and borage oil for eczema.

Authors:  Joel T M Bamford; Sujoy Ray; Alfred Musekiwa; Christel van Gool; Rosemary Humphreys; Edzard Ernst
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice.

Authors:  M Sałaga; U Lewandowska; D Sosnowska; P K Zakrzewski; A I Cygankiewicz; A Piechota-Polańczyk; M Sobczak; P Mosinska; Chunqiu Chen; W M Krajewska; J Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-31       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.